Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | CD4 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Molar mass | 147 kg/mol |
(what is this?) (verify) |
Zanolimumab is an investigational human monoclonal antibody and an immunosuppressive drug. [1] It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, [2] cutaneous and peripheral T-cell lymphoma. [3] [4] Development of the drug was ultimately discontinued with termination of all trials. [5]
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | CD4 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG | |
Chemical and physical data | |
Molar mass | 147 kg/mol |
(what is this?) (verify) |
Zanolimumab is an investigational human monoclonal antibody and an immunosuppressive drug. [1] It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, [2] cutaneous and peripheral T-cell lymphoma. [3] [4] Development of the drug was ultimately discontinued with termination of all trials. [5]